e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Sarcoidosis: clinical
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Characterisation of an experimental mouse model of exposure to nanoparticles. Relevance to human sarcoidosis
Serge Lebecque (Lyon, France), Serge Lebecque, Toufic Renno, Azzak Bentaher, Marine Ponchon, Alain Calender, Jean-François Bernaudin, Dominique Valeyre, Marc Iglarz, Herve Farine, Daniel Strasser, Yves Pacheco
Source:
International Congress 2015 – Sarcoidosis: clinical
Session:
Sarcoidosis: clinical
Session type:
Thematic Poster Session
Number:
847
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Serge Lebecque (Lyon, France), Serge Lebecque, Toufic Renno, Azzak Bentaher, Marine Ponchon, Alain Calender, Jean-François Bernaudin, Dominique Valeyre, Marc Iglarz, Herve Farine, Daniel Strasser, Yves Pacheco. Characterisation of an experimental mouse model of exposure to nanoparticles. Relevance to human sarcoidosis. Eur Respir J 2015; 46: Suppl. 59, 847
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Comparison of two murine models of acute and chronic hypersensitivity pneumonitis due to pigeon serum exposure
Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models
Year: 2015
Developing a chronic murine model that better reflects the clinical features of the human asthma
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Standardization of a murine model of asthma due to soybean inhalation
Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models
Year: 2015
A murine ovalbumin model exhibits molecular features of steroid insensitive human asthma
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Determinants of inflammatory and functional toxicity of silver nanospheres in rat lung
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
Mapping a mouse model of severe asthma to human asthma using gene set variation analysis
Source: International Congress 2015 – Advances in the future treatment of severe asthma
Year: 2015
Acute markers of neutrophilic lung infiltration in the non-human primate LPS model
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Characterization of a new rat model of heritable PAH
Source: International Congress 2016 – Pulmonary hypertension: novel insights
Year: 2016
Targeting IL33-ST2 pathway in virus-induced exacerbation of experimental asthma
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
The role of lL-17 in the OVA-LPS driven model of lung inflammation
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
A novel non-human primate model of cigarette smoke-induced chronic obstructive pulmonary disease
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
The neurogenic inflammation markers in rat’s brain in experimental smoking
Source: International Congress 2016 – Molecular pathways of smoking-induced diseases
Year: 2016
Effects of a highly selective CXCR3 antagonist in two murine models of lung inflammation
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014
Metabolomic profiling of the lung in a murine model of emphysema
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014
Characterization of an endogenous Th17-cell generation during sensitization in the murine lung
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
Influenza infection affects the degree of fibrosis and apoptosis in the bleomycin mouse model
Source: Annual Congress 2013 –Interesting research questions
Year: 2013
Chronic low-grade systemic inflammation causes DNA damage in the lungs of mice
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013
Essential role of IRF-3 in COPD exacerbation mouse model
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
Description of a murine model of acute pneumonitis hypersensitivity to pigeon serum
Source: International Congress 2014 – ILDs 2
Year: 2014
A new model for analysis of chronic bronchial interleukin-8 expression
Source: International Congress 2016 – Airway response to infection
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept